Embla Medical hf Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
601.00
500.00
395.00
542.00
81.00
600.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-60.00
-91.00
-157.00
-131.00
167.00
-144.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
800.00
650.00
430.00
632.00
603.00
636.00
Cash Flow from Investing Activities
-788.00
-393.00
-469.00
-374.00
-712.00
-418.00
Cash Flow from Financing Activities
106.00
-282.00
26.00
-321.00
355.00
-193.00
Net Cash Inflow / Outflow
93.00
-27.00
-60.00
-108.00
286.00
19.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-24.00
-1.00
-48.00
-45.00
39.00
-4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in DKK Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Embla Medical hf
Figures in Million
consolidated Cash Flow Results
Change(DKK)
Change(%)
Profit Before Tax
601.444142213136
300
301.00
100.48%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-60.1906139135144
-114
54.00
47.20%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
800.33036939924
813
-13.00
-1.56%
Cash Flow from Investing Activities
-788.966624213139
-289
-499.00
-173.00%
Cash Flow from Financing Activities
106.25239658533
-65
171.00
263.47%
Net Cash Inflow / Outflow
93.171677763708
458
-365.00
-79.66%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-24.4444640077224
-1
-23.00
-2344.45%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 23.11% vs 51.12% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
800.33
650.08
23.11%






